Ascent Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Ascent Group's LLY Position: Q2 2026 in Review
Ascent Group increased its Eli Lilly (LLY) stake by 8.9% in Q2 2026, buying an estimated $1.58M and bringing the position to 18,846 shares worth $22.6M. The position accounts for 0.68% of the portfolio, ranked #30.
Ascent Group first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Ascent Group held 18,846 shares of Eli Lilly worth $22.6M as of Q2 2026.
- Ascent Group bought 1,544 Eli Lilly shares in Q2 2026, an estimated $1.58M.
- Eli Lilly made up 0.68% of Ascent Group's portfolio in Q2 2026, its #30 holding.
- Ascent Group first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.